10x Genomics, Inc. (TXG) Shareholders’ equity 2017–2025
10x Genomics, Inc. (TXG) shareholders’ equity at each fiscal year-end, per SEC filings.
$796.3MFY2025 · since FY2017: -$112.5M → $796.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $796.3M | +12.1% |
| FY2024 | $710.1M | -4.2% |
| FY2023 | $741.0M | -8.0% |
| FY2022 | $805.7M | -1.4% |
| FY2021 | $817.6M | +10.6% |
| FY2020 | $739.1M | +75.9% |
| FY2019 | $420.1M | +291.0% |
| FY2018 | -$220.0M | -95.5% |
| FY2017 | -$112.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice